p53 and ATM: Cell cycle, cell death, and cancer

Advances in Cancer Research

Volumn 71, Issue , 1997, Pages 24-25

  Morgan, Susan E ^a   Kastan, Michael B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53;

CANCER GENETICS; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL TRANSFORMATION; DNA DAMAGE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0030910037     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (25)

1. Agamanolis, D. P., and Greenstein, J. I. (1979). J. Neuropathol. Exp. Neurol. 38, 475-489.
2. Al-Khodairy, F., and Carr, A. M. (1992). EMBO J. 11, 1343-1350.
3. Al-Khodairy, F., Fotou, E., Sheldrick, K. S., Griffiths, D. J. F., Lehmann, A. R., and Carr, A. M. (1994). Mol. Biol. Cell 5, 147-160.
4. Allen, J. B., Zhou, Z., Siede, W., Friedberg, E. C., and Elledge, S. J. (1994). Genes Dev. 8, 2401-2415.
5. Amromin, G. D., Boder, E., and Teplitz, R. J. (1979). J. Neuropathol. Exp. Neurol. 38, 621-643.
6. Anderson, C. W. (1993). Trends Biochem. Sci. 18, 433-437.
7. Arlett, C. F., and Priestly, A. (1983). Int. J. Radiat. Biol. 43, 157-167.
8. Baker, B. S., Carpenter, A. T. C., and Ripoll, P. (1978). Genetics 90, 531-578.
9. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. (1990). Science 249, 912-915.
10. Banga, S. S., Shenkar, R., and Boyd, J. B. (1986). Mutat. Res. 163, 157-165.
11. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993). EMBO J. 12, 461-468.
12. Beamish, H., Khanna, K. K., and Lavin, M. F. (1994). Radiat. Res. 138, S130-S133.
13. Biedermann, K. A., Sun, J., Giaccia, A. J., Tosto, L. M., and Brown, J. M. (1991). Proc. Natl. Acad. Sci. U.S.A. 88, 1394-1397.
14. Blunt, T., Finnie, J. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, T., Varghese, A. J., Alt, F. W., Jeggo, P. A., and Jackson, S. P. (1995). Cell 80, 813-823.
15. Brachman, D. G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R. R. (1992). Cancer Res. 52, 4832-4836.
16. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S., and Schreiber, S. L. (1994). Nature (London) 369, 756-758.
17. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. (1995). Nature (London) 377, 552-557.
18. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., and Kley, N. (1995). Nature (London) 377, 646-649.
19. Burgering, B. M. T., and Coffer, P. J. (1995). Nature (London) 376, 599-602.
20. Buttke, T. M., and Sandstrom, P. A. (1994). Immunol. Today 15, 7-10.
21. Canman, C. E., Wolff, A. C., Chen, C., Fornace, A. J., and Kastan, M. B. (1994). Cancer Res. 54, 5054-5058.
22. Zambetti, G. P., and Levine, A. J. (1993). FASEB J. 7, 855-865.
23. Zauberman, A., Lupo, A., and Oren, M. (1995). Oncogene 10, 2361-2366.
24. Zhan, Q., Bae, I., Kastan, M. B., and Fornace, A. J., Jr. (1994). Cancer Res. 54, 2755-2760.
25. zur Hausen, H. (1989). In "Advances in Viral Oncology" (G. Klein, Ed.), pp. 1-26. Raven, New York.